Free tool
Dividend paying stocks
We cover 66 companies that currently pay a dividend. The median market value in the group is $4.29B. Across the group, the median move over the past trading day is −0.03%. 66% of the 65 with a 200-day average trade above it. Price change over the past year runs from −26.9% to +54.2% across the middle 80 percent of the group, with a median of +1.0%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
66 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −20.54% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.